NasdaqCM - Delayed Quote USD

NeuroOne Medical Technologies Corporation (NMTC)

1.1300 0.0000 (0.00%)
At close: April 26 at 4:00 PM EDT
1.1100 -0.02 (-1.77%)
After hours: April 26 at 7:38 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. David A. Rosa M.D. President, CEO & Director 759.98k -- 1964
Mr. Ronald W. McClurg Chief Financial Officer 358.79k -- 1960
Mr. Steven Mertens Chief Technology Officer 332.26k -- 1963
Mr. Mark Christianson Co-Founder, Business Development Director & Medical Sales Liaison 260.85k -- 1967
Mr. Christopher R. Volker CFA Chief Operating Officer -- -- --
Mr. Hijaz Haris Vice President of Marketing -- -- --

NeuroOne Medical Technologies Corporation

7599 Anagram Drive
Eden Prairie, MN 55344
United States
952 426 1383 https://www.n1mtc.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
16

Description

NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.

Corporate Governance

NeuroOne Medical Technologies Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

May 09, 2024 - May 13, 2024
NeuroOne Medical Technologies Corporation Earnings Call

Related Tickers

MOTS Motus GI Holdings, Inc.
0.0810
+1.25%
 
HSDT Helius Medical Technologies, Inc.
4.5000
0.00%
 
BSGM BioSig Technologies, Inc.
1.3700
+5.38%
 
BTCY Biotricity, Inc.
1.2800
-1.54%
 
PETV PetVivo Holdings, Inc.
0.8197
+2.46%
 
MODD Modular Medical, Inc.
1.5800
+3.95%
 
MDAI Spectral AI, Inc.
1.8500
+0.54%
 
CLPT ClearPoint Neuro, Inc.
5.26
-0.94%
 
MOVE Movano Inc.
0.4750
-0.38%
 
BMRA Biomerica, Inc.
0.6652
-2.18%